SEOVF (Sernova Biotherapeutics) Total Equity: $-7.01 Mil (As of Apr. 2026)


SEOVF Sernova Biotherapeutics Inc SEOVF
30 GF Score
Price $0.10
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Total Equity?

Sernova Biotherapeutics SEOVF +3.73% 30 Total Equity is $-7.01 Mil as of Apr. 2026. GuruFocus rates SEOVF with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Sernova Biotherapeutics's total equity for the quarter that ended in Apr. 2026 was $-7.01 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Sernova Biotherapeutics Total Equity Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Total Equity Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.57 34.78 9.13 -9.42 -17.93

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.78 -17.85 -17.93 -18.59 -7.01
SEOVF
30GF Score
Sernova Biotherapeutics Inc SEOVF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sernova Biotherapeutics's Total Equity for the fiscal year that ended in Oct. 2025 is calculated as

Total Equity=Total Assets(Q: Oct. 2025 )-Total Liabilities(Q: Oct. 2025 )
=0.546-18.474
=-17.93

Sernova Biotherapeutics's Total Equity for the quarter that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=1.115-8.124
=-7.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-7.01 Mil mean?
Sernova Biotherapeutics (SEOVF) has a Total Equity of $-7.01 Mil as of Apr. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Total Equity too high?
Sernova Biotherapeutics' current Total Equity is $-7.01 Mil. Overall, Sernova Biotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Total Equity compare to VRTX and REGN?
Sernova Biotherapeutics' Total Equity of $-7.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Total Equity is $-7.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (SEOVF) has a current Total Equity of $-7.01 Mil. The current Total Equity is $-7.01 Mil. Sernova Biotherapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Sernova Biotherapeutics (SEOVF), the current Total Equity is $-7.01 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges PSH0:GermanySVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
30GF Score

Get the complete analysis for SEOVF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price